| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
21,380 |
16,907 |
$1.01M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,627 |
5,577 |
$215K |
| 99233 |
Prolong inpt eval add15 m |
4,216 |
1,457 |
$105K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
426 |
390 |
$41K |
| 80305 |
|
3,930 |
3,256 |
$21K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,543 |
1,076 |
$18K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,191 |
471 |
$14K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
135 |
120 |
$14K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
483 |
454 |
$12K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
196 |
150 |
$10K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,832 |
1,494 |
$10K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,179 |
1,941 |
$10K |
| 83013 |
|
228 |
219 |
$9K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
91 |
24 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
697 |
624 |
$7K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
932 |
749 |
$6K |
| 43235 |
|
53 |
50 |
$5K |
| 99215 |
Prolong outpt/office vis |
116 |
93 |
$5K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
104 |
101 |
$5K |
| 70220 |
|
290 |
258 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
825 |
754 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
374 |
333 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
101 |
87 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
116 |
101 |
$3K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
15 |
13 |
$2K |
| 94010 |
|
153 |
145 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,834 |
1,621 |
$2K |
| 72100 |
|
134 |
105 |
$2K |
| 82947 |
|
869 |
741 |
$1K |
| 86308 |
|
345 |
302 |
$1K |
| 83014 |
|
241 |
231 |
$1K |
| 0012A |
|
27 |
27 |
$1K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
247 |
207 |
$1K |
| 99234 |
|
26 |
25 |
$1K |
| 0011A |
|
23 |
23 |
$920.00 |
| 76830 |
Ultrasound, transvaginal |
20 |
14 |
$852.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
549 |
465 |
$718.86 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
471 |
401 |
$662.16 |
| 84443 |
Thyroid stimulating hormone (TSH) |
395 |
364 |
$653.73 |
| 81002 |
|
360 |
302 |
$620.74 |
| 82962 |
|
257 |
227 |
$415.78 |
| 90688 |
|
36 |
25 |
$396.76 |
| 90756 |
|
79 |
60 |
$387.43 |
| 94060 |
|
26 |
26 |
$254.48 |
| 84439 |
|
364 |
334 |
$245.18 |
| 80053 |
Comprehensive metabolic panel |
27 |
24 |
$240.00 |
| 81025 |
|
104 |
89 |
$227.20 |
| 90661 |
|
19 |
12 |
$222.90 |
| 90686 |
|
21 |
15 |
$193.68 |
| 81003 |
|
86 |
73 |
$189.10 |
| 96160 |
|
112 |
103 |
$173.44 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
78 |
35 |
$160.00 |
| 94726 |
|
26 |
26 |
$147.42 |
| 94729 |
|
26 |
26 |
$97.38 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
15 |
12 |
$93.96 |
| 85018 |
|
55 |
47 |
$92.42 |
| 86580 |
|
35 |
12 |
$78.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
27 |
27 |
$63.11 |
| 82272 |
|
26 |
25 |
$48.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
28 |
24 |
$12.43 |
| 94250 |
|
26 |
26 |
$8.64 |
| 1036F |
|
9,349 |
7,591 |
$0.00 |
| 3074F |
|
5,922 |
5,258 |
$0.00 |
| 3079F |
|
2,841 |
2,631 |
$0.00 |
| 3080F |
|
1,119 |
1,042 |
$0.00 |
| 1034F |
|
1,327 |
1,208 |
$0.00 |
| 3075F |
|
1,045 |
990 |
$0.00 |
| 3008F |
|
11,181 |
9,749 |
$0.00 |
| 1126F |
|
136 |
125 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
31 |
29 |
$0.00 |
| 1159F |
|
6,740 |
5,807 |
$0.00 |
| 3078F |
|
4,907 |
4,355 |
$0.00 |
| 1160F |
|
7,537 |
6,513 |
$0.00 |
| 3077F |
|
2,361 |
2,164 |
$0.00 |
| 3725F |
|
881 |
747 |
$0.00 |
| 99080 |
|
179 |
132 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
32 |
27 |
$0.00 |